Hepatitis C News and Research

Latest Hepatitis C News and Research

Vaccines can be blamed for any illness even with lack of evidence says EU court

In a landmark judgment yesterday, the Court of Justice of the European Union ruled that courts could consider vaccines to be the reason for an illness despite the absence of any concrete evidence to support the connection.

21 Jun 2017

A ‘safe’ space to shoot up: Worth a try in California?

Tawny Biggs' seemingly happy childhood in the northern Los Angeles County suburb of Santa Clarita, Calif., showed no outward sign that she would one day struggle with drug addiction.

19 Jun 2017

Exclusive: White House task force echoes pharma proposals

President Donald Trump repeatedly talks tough about reining in the pharmaceutical industry, but his administration's efforts to lower drug prices are shrouded in secrecy.

16 Jun 2017

People in recovery worry GOP Medicaid cuts would put treatment out of reach

Republicans in both the House and the Senate are considering big cuts to Medicaid. But those cuts endanger addiction treatment, which many people receive through the government health insurance program.

14 Jun 2017

Survey finds parents to be least knowledgeable about invasive pneumococcal disease

Pfizer Inc., in partnership with Parents magazine, announced today the results of a national survey of more than 2,000 new and expectant parents assessing their knowledge of childhood infectious diseases, such as measles, whooping cough and invasive pneumococcal disease, and the measures parents can take to help prevent them.

14 Jun 2017

Opana ER – a long acting opioid painkiller, to be pulled from the markets as per FDA directive

The US Food and Drug Administration this Thursday (8th June 2017) directed pharmaceutical company Endo Pharmaceuticals to remove one of its powerful opioid painkillers Opana ER, that provides a long term relief of pain but also poses a risk of drug abuse.

9 Jun 2017

UNC researchers identify how class of antiviral drugs interacts with HCV

Globally, an estimated 71 million people are living with chronic hepatitis C virus (HCV). Over decades of infection, chronic HCV infection results in progressive damage to the liver and an increased risk for end stage liver disease and liver cancer, making the virus the leading cause of liver-related deaths in the United States today.

9 Jun 2017

Heroin use in the U.S. estimated to cost society more than $51 billion

Heroin use in the United States was estimated to cost society more than $51 billion in 2015, according to new research at the University of Illinois at Chicago.

9 Jun 2017

Drinking few cups of coffee or tea may protect against liver fibrosis, study finds

Chronic liver diseases rank as the 12th cause of death worldwide and many of these disorders are associated with unhealthy lifestyles. Conversely, a healthier lifestyle can help prevent or reverse liver disease.

6 Jun 2017

Survey finds wide variation in hepatitis B, C testing policy and practice across the EU/EEA

The survey results suggest a wide variation in existing national testing policy and practice when it comes to hepatitis B and C - with overall limited monitoring of testing, diagnosis, and treatment across EU/EEA Member States.

1 Jun 2017

Grifols provides Procleix Zika Virus Assay to screen blood donations in countries that accept products with CE marking

Grifols, one of the world’s leading producers of plasma-derived medicines, now provides European countries accepting products with the CE marking with a test to detect the presence of the Zika virus in donated blood. CE marking means a product conforms to relevant legislation for sale in the European economic area.

29 May 2017

New drug offers hope to patients with hepatitis C

Patients with hepatitis C who suffer from advanced stages of liver disease have renewed hope, thanks to findings by researchers who have discovered that a new drug significantly reduces their risk of death and need for transplantation.

26 May 2017

FDA grants accelerated approval to cancer treatment based on common biomarker

The U.S. Food and Drug Administration today granted accelerated approval to a treatment for patients whose cancers have a specific genetic feature (biomarker).

23 May 2017

Seventh Wave announces collaboration with Yecuris to study new liver disease therapies

Seventh Wave Laboratories, a consulting-based contract research organization that assesses the safety and efficacy of pharmaceutical products and medical devices, has announced an exclusive collaboration with Yecuris Corporation, a global leader in the development and use of humanized models in drug development research.

18 May 2017

Researchers develop new strategy that can revolutionize HIV vaccine design

Vaccines are an essential tool for preventing and treating serious infectious diseases such as polio, chicken pox and measles. But so far it has not been possible to develop vaccines capable of contributing to the treatment and prevention of chronic infectious diseases such as HIV and hepatitis C.

17 May 2017

Study finds substantial increase in hepatitis C infections among pregnant women

Hepatitis C infections among pregnant women nearly doubled from 2009-2014, likely a consequence of the country's increasing opioid epidemic that is disproportionately affecting rural areas of states including Tennessee and West Virginia.

11 May 2017

Statins may provide favorable effects in patients with HBV- or HCV-related cirrhosis

Infection with hepatitis B virus (HBV) or hepatitis C virus (HCV) can lead to cirrhosis as well as liver cancer. A Hepatology study from Taiwan has found that statins may provide benefits to patients with HBV- or HCV-related cirrhosis.

8 May 2017

Study uncovers potential new therapeutic targets for HCV infections

An international study led by researchers at Monash University' Biomedicine Discovery Institute (BDI) has shone light on the way the Hepatitis C Virus (HCV) hijacks the communication systems in the host cells it infects, uncovering potential new therapeutic targets for the disease.

8 May 2017

Specific genotype may predict recovery in patients with advanced cirrhosis after hepatitis c treatment

Genotyping of patients with advanced cirrhosis from hepatitis C virus could help health-care professionals predict the likelihood of improvement after successful hepatitis C treatment, thus minimizing the need for liver transplants.

8 May 2017

Researchers uncover new mechanism that explains cause of portal hypertension

Investigators at the Medical University of South Carolina have identified a critical regulatory mechanism for the production of nitric oxide. Endothelial nitric oxide synthase is the enzyme responsible for the production of NO and its activity is tightly controlled in liver endothelial cells via a series of complex molecular mechanisms; however, in liver injury, eNOS activity, and subsequently NO production, is dysregulated.

3 May 2017

Hepatitis C News and Research

Latest Hepatitis C News and Research

Vaccines can be blamed for any illness even with lack of evidence says EU court

A ‘safe’ space to shoot up: Worth a try in California?

Exclusive: White House task force echoes pharma proposals

People in recovery worry GOP Medicaid cuts would put treatment out of reach

Survey finds parents to be least knowledgeable about invasive pneumococcal disease

Opana ER – a long acting opioid painkiller, to be pulled from the markets as per FDA directive

UNC researchers identify how class of antiviral drugs interacts with HCV

Heroin use in the U.S. estimated to cost society more than $51 billion

Drinking few cups of coffee or tea may protect against liver fibrosis, study finds

Survey finds wide variation in hepatitis B, C testing policy and practice across the EU/EEA

Grifols provides Procleix Zika Virus Assay to screen blood donations in countries that accept products with CE marking

New drug offers hope to patients with hepatitis C

FDA grants accelerated approval to cancer treatment based on common biomarker

Seventh Wave announces collaboration with Yecuris to study new liver disease therapies

Researchers develop new strategy that can revolutionize HIV vaccine design

Study finds substantial increase in hepatitis C infections among pregnant women

Statins may provide favorable effects in patients with HBV- or HCV-related cirrhosis

Study uncovers potential new therapeutic targets for HCV infections

Specific genotype may predict recovery in patients with advanced cirrhosis after hepatitis c treatment

Researchers uncover new mechanism that explains cause of portal hypertension

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Hepatitis C News and Research

Latest Hepatitis C News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in